Status:
COMPLETED
Acceptance and Commitment Therapy Principles for Diabetes Prevention
Lead Sponsor:
University of Oregon
Conditions:
PreDiabetes
Diabetes Mellitus, Type 2
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The investigators will evaluate whether a brief intervention (i.e. a workbook and video presenting educational information and activities materials for diabetes prevention) that incorporates principle...
Detailed Description
The investigators aim for this study to represent community-based, participatory research which is accessible, effective, understandable, and minimizing of stigma. Prior to conducting the study, the i...
Eligibility Criteria
Inclusion
- United States Residency
- 90% or higher Human Intelligence Task completion ratings (ratings which are assigned by mTurk researchers to workers upon completion of a Human Intelligence Task , and to indicate quality of worker history with mTurk).
- At least 18 years of age
- English-speaking
- High-risk for Type 2 Diabetes, as indicated by a score of 5 or greater on the American Diabetes Association's diabetes risk test.
Exclusion
- Having been enrolled in a lifestyle program for diabetes prevention presently or within the past year.
- Type 1 Diabetes diagnosis
- Type 2 Diabetes diagnosis
Key Trial Info
Start Date :
August 28 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 21 2021
Estimated Enrollment :
301 Patients enrolled
Trial Details
Trial ID
NCT05260983
Start Date
August 28 2021
End Date
September 21 2021
Last Update
March 2 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Oregon - Social Affective Neuroscience Lab
Eugene, Oregon, United States, 97403